U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
157390157390Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNo Results AvailableCognitive/Functional Effects|Depression|Leukemiahttps://ClinicalTrials.gov/show/NCT00499785
157391157391Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic LeukemiaCompletedNo Results AvailableDepression|Fatigue|Leukemia|Musculoskeletal Complications|Psychosocial Effects of Cancer and Its TreatmentBehavioral: Resting vitals|Behavioral: Body Composition|Behavioral: Timed Get-up and Go test (TGUG).|Behavioral: Cardiorespiratory assessment|Behavioral: Handgrip evaluation|Behavioral: Dynamic muscular endurancehttps://ClinicalTrials.gov/show/NCT00499759
157392157392The Discriminative Effects of Tramadol in HumansCompletedNo Results AvailableOpioid Abuse|Opioid Addiction|Stimulant Abuse|Stimulant AddictionDrug: tramadol|Drug: hydromorphone|Drug: methylphenidate|Drug: placebohttps://ClinicalTrials.gov/show/NCT00499746
157393157393Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerRecruitingNo Results AvailableCancerDrug: cyclophosphamide|Other: laboratory biomarker analysis|Procedure: biopsy|Procedure: cryosurgeryhttps://ClinicalTrials.gov/show/NCT00499733
157394157394Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway InfectionApproved for marketingNo Results AvailableCystic Fibrosis|Pseudomonas Aeruginosa Airway InfectionDrug: Aztreonam Lysine for Inhalationhttps://ClinicalTrials.gov/show/NCT00499720
157395157395Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes SubjectsCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: rosiglitazone maleate/metformin hydrochloridehttps://ClinicalTrials.gov/show/NCT00499707
157396157396Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With DocetaxelCompletedHas ResultsProstate CancerBiological: bevacizumab|Drug: satraplatinhttps://ClinicalTrials.gov/show/NCT00499694
157397157397PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORETerminatedHas ResultsBreast CancerDrug: lapatinib ditosylate|Drug: letrozole|Other: placebohttps://ClinicalTrials.gov/show/NCT00499681
157398157398Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With CancerWithdrawnNo Results AvailableMyeloproliferative Disorders|Leukemia|Lymphoma|Lymphoproliferative Disorder|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Nausea and Vomiting|Solid TumorDrug: aprepitant|Drug: ondansetron hydrochloridehttps://ClinicalTrials.gov/show/NCT00499668
157399157399Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung CancerActive, not recruitingNo Results AvailableRecurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung CancerDrug: erlotinib hydrochloride|Drug: celecoxib|Other: placebo|Other: laboratory biomarker analysis|Other: immunohistochemistry staining method|Genetic: fluorescence in situ hybridization|Genetic: mutation analysis|Genetic: protein expression analysis|Genetic: gene expression analysishttps://ClinicalTrials.gov/show/NCT00499655
157381157381Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a StrokeTerminatedNo Results AvailableAcute Ischemic StrokeDrug: alfimeprasehttps://ClinicalTrials.gov/show/NCT00499902
157400157400Study Evaluating the Effect of Lecozotan SR on the QTc IntervalCompletedNo Results AvailableAlzheimer Disease|HealthyDrug: Lecozotan SR|Drug: Moxifloxacinhttps://ClinicalTrials.gov/show/NCT00499642
157401157401Study Evaluating the Safety of FXR-450 in Healthy SubjectsCompletedNo Results AvailableHealthyDrug: FXR 450|Drug: placebohttps://ClinicalTrials.gov/show/NCT00499629
157402157402Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With NeuroblastomaActive, not recruitingNo Results AvailableNeuroblastomaDrug: carboplatin|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: etoposide|Drug: topotecan hydrochloride|Drug: Isotretinoinhttps://ClinicalTrials.gov/show/NCT00499616
157403157403Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast CancerActive, not recruitingHas ResultsBreast CancerDrug: Paclitaxel|Drug: 5-Fluorouracil|Drug: Epirubicin|Drug: Cyclophosphamide|Drug: RAD001https://ClinicalTrials.gov/show/NCT00499603
157404157404Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMDTerminatedHas ResultsMacular DegenerationDrug: bevasiranib|Drug: ranibizumabhttps://ClinicalTrials.gov/show/NCT00499590
157405157405Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple MyelomaCompletedNo Results AvailableMultiple Myeloma and Plasma Cell NeoplasmBiological: CMV pp65 peptide|Biological: hTERT I540/R572Y/D988Y multipeptide vaccine|Biological: pneumococcal polyvalent vaccine|Biological: survivin Sur1M2 peptide vaccinehttps://ClinicalTrials.gov/show/NCT00499577
157406157406A Phase I/IIa Study for the Treatment of Uveitis With IontophoresisWithdrawnNo Results AvailableUveitisDevice: Iontophoresis second generation Eyegate II devicehttps://ClinicalTrials.gov/show/NCT00499551
157407157407Study Evaluating 3 New Formulations of SKI-606 in Healthy Adult SubjectsCompletedNo Results AvailableHealthyDrug: SKI-606https://ClinicalTrials.gov/show/NCT00499538
157408157408Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast CancerActive, not recruitingNo Results AvailableBreast CancerDrug: paclitaxel|Drug: sorafenib tosylate|Other: placebohttps://ClinicalTrials.gov/show/NCT00499525
157382157382Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML PatientsTerminatedHas ResultsLeukemiaDrug: Imatinib Mesylate|Drug: Fludarabine (Fludara)|Drug: Busulfan|Drug: Antithymocyte Globulin (ATG)|Drug: Tacrolimus|Drug: Methotrexate|Procedure: Donor lymphocyte infusion (DLI)|Procedure: Stem Cell Transplanthttps://ClinicalTrials.gov/show/NCT00499889
157383157383The Effect of Malaria on Disease Progression of HIV/AIDSActive, not recruitingNo Results AvailableHIV Infections|MalariaDrug: mefloquine|Other: placebohttps://ClinicalTrials.gov/show/NCT00499876
157384157384Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHDCompletedHas ResultsADHDDrug: methylphenidate transdermal system|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00499863
157385157385Phase I FOLFOX CombinationCompletedNo Results AvailableAdvanced Colorectal CarcinomaDrug: ZD6474 (vandetanib)|Drug: 5-Fluorouracil|Drug: Leucovorin|Drug: Oxaliplatinhttps://ClinicalTrials.gov/show/NCT00499850
157386157386Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis PatientsCompletedNo Results AvailableCystic FibrosisDrug: Aerosolized, human, plasma-derived Alpha-1 Antitrypsinhttps://ClinicalTrials.gov/show/NCT00499837
157387157387GIANT: General Practitioner Implementation in Asia of Normoglycaemic TargetsCompletedNo Results AvailableType 2 Diabetes MellitusBehavioral: Education of general practitioners on the IDF-WPR guidelineshttps://ClinicalTrials.gov/show/NCT00499824
157388157388Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver DysfunctionCompletedNo Results AvailableAdult Grade III Lymphomatoid Granulomatosis|Adult Nasal Type Extranodal NK/T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associateDrug: vorinostat|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00499811
157389157389Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain TumorsCompletedNo Results AvailableBrain and Central Nervous System Tumors|Chemotherapeutic Agent Toxicity|Infertilityhttps://ClinicalTrials.gov/show/NCT00499798
157409157409Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube CancerActive, not recruitingNo Results AvailableOvarian Cancer|Peritoneal Cancer|Fallopian Tube CancerBehavioral: Questionnairehttps://ClinicalTrials.gov/show/NCT00499512
157410157410A Dose Escalation Study of E7107 Administered Intravenously on Days 1 and 8 Every 21 Days to Patients With Solid TumorsSuspendedNo Results AvailableCancerDrug: E7107https://ClinicalTrials.gov/show/NCT00499499

* Görseller ve İçerik tekif hakkına sahip olabilir